NCT01666808View on ClinicalTrials.gov

FACBC Outcomes for Post Prostatectomy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 18, 2022

Study Completion Date

April 18, 2022

Conditions
Prostate Cancer
Interventions
DRUG

FACBC

FACBC is given intravenously prior to PET scan, radiotherapy decisions and treatment guided by PET findings

RADIATION

Radiation therapy

External beam radiotherapy to prostate bed +/- pelvic lymph nodes; final dose of 66.6 Gy.

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER

NCT01666808 - FACBC Outcomes for Post Prostatectomy | Biotech Hunter | Biotech Hunter